Exploring pharmacy provision of medication abortion pills in Nepal: a mixed-methods study of pharmacy workers' knowledge and practices. [PDF]
Sex Reprod Health MattersRijal N, Foster AM.
europepmc +1 more source
Abortifacient Drugs and Devices: Medical and Moral Dilemmas [PDF]
, 1990 Severyn, Kristine M.
core +1 more source
Response to comment on Buse et al. Prevalence of Hypercortisolism in Difficult-to-Control Type 2 Diabetes. Diabetes Care 2025;48:2012-2020. [PDF]
Diabetes CareBuse JB +3 more
europepmc +1 more source
Endometrial Changes Associated with Mifepristone: A Review. [PDF]
Int J Gen MedLin Q, Zhou Y.
europepmc +1 more source
Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer. [PDF]
OncotargetSequeira G +7 more
europepmc +1 more source
Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS? [PDF]
, 2015 core +1 more source
Exploring the mechanism of Zishen Quyu Jiedu formula in treating endometriosis based on network pharmacology and experimental verification. [PDF]
Front Endocrinol (Lausanne)Wang R, Tian X, Liu P, Lian F.
europepmc +1 more source
Early Pregnancy Termination with Mifepristone and Misoprostol: Concurrent vs. 48-Hour Interval Administration in a Randomized Controlled Trial. [PDF]
J Clin MedBraverman M +4 more
europepmc +1 more source
Aurora Kinase A inhibitor alisertib failed to exert its efficacy on TNBC cells due to consequential enrichment of polyploid giant cancer cells (PGCCs). [PDF]
Discov OncolThakur D +10 more
europepmc +1 more source
Pharmacist Dispensing of Mifepristone: Evaluation of Knowledge and Support Before and After a Continuing Education Course. [PDF]
Pharmacy (Basel)Morris N +4 more
europepmc +1 more source